Global Buzz: Hugel's Letybo FDA Approval in Aesthetic Medicine

Hugel, a global pharmaceutical company, received FDA approval for their new botulinum toxin, Letybo, marking a milestone in aesthetic medicine. Letybo offers a new option for anti-aging treatments, catering to physicians and patients seeking innovative solutions in the realm of non-surgical aesthetics. This development signifies progress in enhancing natural beauty, shaping the future of aesthetic medicine.Stay connected with Dr. Teri Fisher and keep up with the latest in aesthetic medicine: ...